Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

NCT05687110 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

43

Enrollment

NIH

Sponsor class

Conditions

Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Diagnostic Imaging Testing
BIOLOGICAL: Novobiocin Sodium

Sponsor

National Cancer Institute (NCI)